PAT-07

Phase 2

Recruiting

• Conditions: Borderline resectable pancreatic cancer; Borderline resectable, pancreatic cancer; D021441

• Registration Number: JPRN-jRCTs041200028
• Lead Sponsor: Kodera Yasuhiro

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-09
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1.Borderline resectable pancreatic cancer
2.Age 20=< and =<79
3.Performance status 0-1

Exclusion Criteria

1.distant metastasis
2.severe drug allergy
3.viable multiple primary cancer
4.gastrointestinal invasion
5.apparent infectious status
6.history of abdominal radiotherapy
7.pregnant or breastfeeding female

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
R0 resection rate

Secondary Outcome Measures

Name	Time	Method
2-years local recurrence rate, recurrence free survival, overall survival, pathological tumor reduction according to Evans grade, Tumor response defined by RECIST, rate of completion of preoperative therapy, rate of adverse effect, surgical morbidity